Deutsche Boerse Q3 Profit Rises

Deutsche Boerse AG (DBOEY.PK,DBOEF.PK) Tuesday reported that its third-quarter net profit to shareholders rose year-on-year to 300.3 million euros from 227.1 million euros. Earnings per basic share was 1.64 euros, up from 1.24 euros last year.

Third-quarter revenues rose 18% to 837.9 million euros from 707.5 million euros last year.

Earnings before interest, tax, depreciation and amortization (EBITDA) rose to 499.5 million euros, up 25% to 399.5 million euros last year.

Looking forward, the group confirmed its guidance of increasing net revenue to around 3.5 billion euros and EBITDA to around 2.0 billion euros in the full year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT